Cargando…
Promise of Neurorestoration and Mitochondrial Biogenesis in Parkinson's Disease with Multi Target Drugs: An Alternative to Stem Cell Therapy
There is an unmet need in progressive neurodegenerative diseases such as Parkinson's and Alzheimer's diseases. The present therapeutics for these diseases at best is symptomatic and is not able to delay disease or possess disease modifying activity. Thus an approach to drug design should b...
Autores principales: | Youdim, Moussa BH, Oh, Young J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Brain and Neural Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3807004/ https://www.ncbi.nlm.nih.gov/pubmed/24167412 http://dx.doi.org/10.5607/en.2013.22.3.167 |
Ejemplares similares
-
Multi Target Neuroprotective and Neurorestorative Anti-Parkinson and Anti-Alzheimer Drugs Ladostigil and M30 Derived from Rasagiline
por: Youdim, Moussa B.H.
Publicado: (2013) -
Why Do We Need Multifunctional Neuroprotective and Neurorestorative
Drugs for Parkinson’s and Alzheimer’s Disorders?
por: Youdim, Moussa B. H.
Publicado: (2010) -
Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson's and Alzheimer's Diseases as Disease Modifying Agents
por: Youdim, Moussa B. H.
Publicado: (2010) -
A neurorestorative approach to Parkinson's disease
por: Diana, Giovanni, et al.
Publicado: (2017) -
Stem Cell-Based Neuroprotective and Neurorestorative Strategies
por: Hung, Chia-Wei, et al.
Publicado: (2010)